4 active not recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 4 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Ascorbic Acid: new trials by email Literature Review of Ascorbic Acid trials Research Report on Ascorbic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression Zinc, Chromium, Vitamin C, and Copper Supplementation, Standard healthy lifestyle intervention, Placebo - PreDiabetes, Nutrition | Phase 2 | Active not recruiting | Universitas Indonesia | 670 | 2021-06-23 | 2024-11-05 |
| Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients Ascorbic Acid - Bladder Cancer | Phase 1 / Phase 2 | Active not recruiting | University of Kansas Medical Center | 12 | 2019-10-17 | 2025-03-25 |
| A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC Radiation Therapy, Paclitaxel, Carboplatin - Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer | Phase 2 | Active not recruiting | Joseph J. Cullen, MD, FACS | 43 | 2018-11-16 | 2026-07-31 |
| A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme Temozolomide, radiation therapy, Ascorbic Acid - Glioblastoma Multiforme | Phase 2 | Active not recruiting | Bryan Allen | 90 | 2017-03-13 | 2026-09-30 |
Carcinoma, Non-Small-Cell Lung (1) · Glioblastoma (1) · Prediabetic State (1) · Urinary Bladder Neoplasms (1)
Bryan Allen (1) · Joseph J. Cullen, MD, FACS (1) · Universitas Indonesia (1) · University of Kansas Medical Center (1)
United States (3) · Indonesia (1)
Bryan G. Allen, MD, PhD (1) · John Taylor, MD MS (1) · Joseph J Cullen, MD, FACS (1) · Rina Agustina, MD, MSc, PhD (1)
P01CA217797 (1), P30CA086862 (1), U01CA140206 (1), UL1TR002366 (1)